Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 CAD | +12.43% | 0.00% | +40.34% |
04-22 | XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal | MT |
04-08 | XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors | CI |
Business Summary
Number of employees: 3
Managers
Managers | Title | Age | Since |
---|---|---|---|
Allen Davidoff
FOU | Founder | 64 | 08/01/18 |
Jim Fairbairn
DFI | Director of Finance/CFO | 65 | 05/11/18 |
Stephen Haworth
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/21 |
David MacDonald
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/22 |
Stacy Evans
PRN | Corporate Officer/Principal | - | 15/11/22 |
Brian Mangal
PRN | Corporate Officer/Principal | - | - |
Charlotte May
SEC | Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul van Damme
BRD | Director/Board Member | - | 24/01/18 |
Allen Davidoff
FOU | Founder | 64 | 08/01/18 |
Chairman | 67 | 05/06/22 | |
Raymond Pratt
BRD | Director/Board Member | 73 | 19/12/21 |
William Farley
BRD | Director/Board Member | 68 | 11/05/21 |
Patrick Treanor
BRD | Director/Board Member | - | 12-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,998,848 | 1,917,354 ( 95.92 %) | 0 | 95.92 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+40.34% | 8.62M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- XRTX Stock
- Company XORTX Therapeutics Inc.